Wird geladen...
Lenvatinib induces anticancer activity in gallbladder cancer by targeting AKT
Gallbladder cancer (GBC) is characterized by poor prognosis, early metastasis, and high recurrence rates, which seriously threaten human health. The effect of lenvatinib, a widely used drug in anti-hepatocellular carcinoma in China, on GBC progress, as well as its underlying molecular mechanism, rem...
Gespeichert in:
| Veröffentlicht in: | J Cancer |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Ivyspring International Publisher
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8120192/ https://ncbi.nlm.nih.gov/pubmed/33995632 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.50292 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|